{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:12:51Z","timestamp":1779081171401,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["CTF-2023-01-003"],"award-info":[{"award-number":["CTF-2023-01-003"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP21\/00038"],"award-info":[{"award-number":["CP21\/00038"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR01066"],"award-info":[{"award-number":["2021 SGR01066"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2023-144251"],"award-info":[{"award-number":["CNS2023-144251"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00508-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T03:41:25Z","timestamp":1764042085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel susceptibility genes for non-NF2-\/LZTR1-\/SMARCB1-related hereditary schwannomatosis"],"prefix":"10.1007","volume":"24","author":[{"given":"Clara","family":"Nogu\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lluis","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hasselblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9434-6288","authenticated-orcid":false,"given":"Barbara","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"9","key":"508_CR1","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24(9):1967\u20131977. https:\/\/doi.org\/10.1016\/j.gim.2022.05.007","journal-title":"Genet Med"},{"issue":"4","key":"508_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/513207","volume":"80","author":"TJ Hulsebos","year":"2007","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80(4):805\u2013810. https:\/\/doi.org\/10.1086\/513207","journal-title":"Am J Hum Genet"},{"issue":"2","key":"508_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng.2855","volume":"46","author":"A Piotrowski","year":"2014","unstructured":"Piotrowski A et al (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46(2):182\u2013187. https:\/\/doi.org\/10.1038\/ng.2855","journal-title":"Nat Genet"},{"issue":"7","key":"508_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41431-022-01086-x","volume":"30","author":"DG Evans","year":"2022","unstructured":"Evans DG et al (2022) ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis. Eur J Hum Genet 30(7):812\u2013817. https:\/\/doi.org\/10.1038\/s41431-022-01086-x","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"508_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmg-2024-110065","volume":"61","author":"C Forde","year":"2024","unstructured":"Forde C et al (2024) Related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study. J Med Genet 61(9):856\u2013860. https:\/\/doi.org\/10.1136\/jmg-2024-110065","journal-title":"J Med Genet"},{"issue":"11","key":"508_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S et al (2016) The genomic landscape of schwannoma. Nat Genet 48(11):1339\u20131348. https:\/\/doi.org\/10.1038\/ng.3688","journal-title":"Nat Genet"},{"issue":"1","key":"508_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00401-020-02230-x","volume":"141","author":"S Mansouri","year":"2021","unstructured":"Mansouri S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141(1):101\u2013116. https:\/\/doi.org\/10.1007\/s00401-020-02230-x","journal-title":"Acta Neuropathol"},{"issue":"24","key":"508_CR8","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1101\/gad.1262504","volume":"18","author":"J Han","year":"2004","unstructured":"Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18(24):3016\u20133027. https:\/\/doi.org\/10.1101\/gad.1262504","journal-title":"Genes Dev"},{"issue":"3","key":"508_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI130206","volume":"130","author":"B Rivera","year":"2020","unstructured":"Rivera B et al (2020) DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis. J Clin Invest 130(3):1479\u20131490. https:\/\/doi.org\/10.1172\/JCI130206","journal-title":"J Clin Invest"},{"key":"508_CR10","unstructured":"C. International Agency for Research on and O. World Health, B. Who Classification of Tumours Editorial, Ed. WHO Classification of Endocrine and Neuroendocrine Tumors, 5 ed. IARC, 2022"},{"issue":"4","key":"508_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00401-023-02546-4","volume":"145","author":"F Chan-Pak-Choon","year":"2023","unstructured":"Chan-Pak-Choon F et al (2023) SMARCA4-associated schwannomatosis. Acta Neuropathol 145(4):505\u2013507. https:\/\/doi.org\/10.1007\/s00401-023-02546-4","journal-title":"Acta Neuropathol"},{"issue":"1","key":"508_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00401-021-02387-z","volume":"143","author":"C Nogu\u00e9","year":"2022","unstructured":"Nogu\u00e9 C et al (2022) DGCR8 and the six hit, three-step model of schwannomatosis. Acta Neuropathol 143(1):115\u2013117. https:\/\/doi.org\/10.1007\/s00401-021-02387-z","journal-title":"Acta Neuropathol"},{"issue":"7","key":"508_CR13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1210\/clinem\/dgae034","volume":"109","author":"V Condello","year":"2024","unstructured":"Condello V et al (2024) Prevalence, molecular landscape, and clinical impact of DICER1 and DGCR8 mutated follicular-patterned thyroid nodules. J Clin Endocrinol Metab 109(7):1733\u20131744. https:\/\/doi.org\/10.1210\/clinem\/dgae034","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"508_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN (2017) Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet 136(4):349\u2013376. https:\/\/doi.org\/10.1007\/s00439-017-1766-y","journal-title":"Hum Genet"},{"issue":"6","key":"508_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00401-020-02139-5","volume":"139","author":"L de Kock","year":"2020","unstructured":"de Kock L, Rivera B, Foulkes WD (2020) Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8. Acta Neuropathol 139(6):1115\u20131118. https:\/\/doi.org\/10.1007\/s00401-020-02139-5","journal-title":"Acta Neuropathol"},{"issue":"2","key":"508_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-019-02106-9","volume":"139","author":"APY Liu","year":"2020","unstructured":"Liu APY et al (2020) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol 139(2):259\u2013271. https:\/\/doi.org\/10.1007\/s00401-019-02106-9","journal-title":"Acta Neuropathol"},{"key":"508_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226434","author":"L Nguyen","year":"2018","unstructured":"Nguyen L, Crawford JR (2018) Pineoblastoma in a child with 22q11.2 deletion syndrome. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-226434","journal-title":"BMJ Case Rep"},{"issue":"2","key":"508_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-019-02111-y","volume":"139","author":"BK Li","year":"2020","unstructured":"Li BK et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a rare brain tumor consortium registry study. Acta Neuropathol 139(2):223\u2013241. https:\/\/doi.org\/10.1007\/s00401-019-02111-y","journal-title":"Acta Neuropathol"},{"issue":"5","key":"508_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00401-021-02284-5","volume":"141","author":"APY Liu","year":"2021","unstructured":"Liu APY et al (2021) Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol 141(5):771\u2013785. https:\/\/doi.org\/10.1007\/s00401-021-02284-5","journal-title":"Acta Neuropathol"},{"issue":"9","key":"508_CR20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41436-021-01175-0","volume":"23","author":"DG Evans","year":"2021","unstructured":"Evans DG et al (2021) Typical 22q11.2 deletion syndrome appears to confer a reduced risk of schwannoma. Genet Med 23(9):1779\u20131782. https:\/\/doi.org\/10.1038\/s41436-021-01175-0","journal-title":"Genet Med"},{"issue":"12","key":"508_CR21","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.3390\/cimb45120633","volume":"45","author":"HF Bahmad","year":"2023","unstructured":"Bahmad HF et al (2023) Clinical significance of SOX10 expression in human pathology. Curr Issues Mol Biol 45(12):10131\u201310158. https:\/\/doi.org\/10.3390\/cimb45120633","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"508_CR22","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1055\/s-0039-1685457","volume":"14","author":"RA Morshed","year":"2019","unstructured":"Morshed RA, Lee AT, Lee YM, Chin CT, Jacques L (2019) Schwannomatosis of the spinal accessory nerve: a case report. J Brachial Plex Peripher Nerve Inj 14(1):e9\u2013e13. https:\/\/doi.org\/10.1055\/s-0039-1685457","journal-title":"J Brachial Plex Peripher Nerve Inj"},{"issue":"11","key":"508_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/jnen\/nlad080","volume":"82","author":"AA Wali","year":"2023","unstructured":"Wali AA, Yang R, Merbs SL, Rodriguez FJ, Eberhart CG, Lucas CG (2023) Orbital SOX10-mutant schwannoma with plexiform growth: Expanding the histopathological spectrum of a new molecular group. J Neuropathol Exp Neurol 82(11):963\u2013965. https:\/\/doi.org\/10.1093\/jnen\/nlad080","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"508_CR24","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/neuonc\/noad121","volume":"25","author":"EA Williams","year":"2023","unstructured":"Williams EA et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol 25(12):2221\u20132236. https:\/\/doi.org\/10.1093\/neuonc\/noad121","journal-title":"Neuro Oncol"},{"issue":"6","key":"508_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00401-023-02641-6","volume":"146","author":"M Terry","year":"2023","unstructured":"Terry M et al (2023) Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. Acta Neuropathol 146(6):857\u2013860. https:\/\/doi.org\/10.1007\/s00401-023-02641-6","journal-title":"Acta Neuropathol"},{"issue":"3","key":"508_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/path.6426","volume":"266","author":"PH Lee","year":"2025","unstructured":"Lee PH et al (2025) In-frame insertions of SOX10 are highly enriched and characterize a distinct transcriptomic profile in gastrointestinal schwannomas. J Pathol 266(3):268\u2013279. https:\/\/doi.org\/10.1002\/path.6426","journal-title":"J Pathol"},{"issue":"26","key":"508_CR27","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/sj.onc.1202737","volume":"18","author":"KD Robertson","year":"1999","unstructured":"Robertson KD, Jones PA (1999) Tissue-specific alternative splicing in the human INK4a\/ARF cell cycle regulatory locus. Oncogene 18(26):3810\u20133820. https:\/\/doi.org\/10.1038\/sj.onc.1202737","journal-title":"Oncogene"},{"issue":"6","key":"508_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","volume":"83","author":"DE Quelle","year":"1995","unstructured":"Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83(6):993\u20131000. https:\/\/doi.org\/10.1016\/0092-8674(95)90214-7","journal-title":"Cell"},{"issue":"20","key":"508_CR29","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","volume":"66","author":"AM Goldstein","year":"2006","unstructured":"Goldstein AM et al (2006) High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 66(20):9818\u20139828. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0494","journal-title":"Cancer Res"},{"issue":"2","key":"508_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jmg.2006.043802","volume":"44","author":"AM Goldstein","year":"2007","unstructured":"Goldstein AM et al (2007) Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 44(2):99\u2013106. https:\/\/doi.org\/10.1136\/jmg.2006.043802","journal-title":"J Med Genet"},{"issue":"9","key":"508_CR31","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1097\/00005537-200209000-00010","volume":"112","author":"KK Yu","year":"2002","unstructured":"Yu KK, Zanation AM, Moss JR, Yarbrough WG (2002) Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope 112(9):1587\u20131593. https:\/\/doi.org\/10.1097\/00005537-200209000-00010","journal-title":"Laryngoscope"},{"issue":"3","key":"508_CR32","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.1002\/hed.21911","volume":"35","author":"R Cabanillas","year":"2013","unstructured":"Cabanillas R et al (2013) Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas. Head Neck 35(3):E80\u2013E84. https:\/\/doi.org\/10.1002\/hed.21911","journal-title":"Head Neck"},{"issue":"21","key":"508_CR33","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","volume":"14","author":"FA de Snoo","year":"2008","unstructured":"de Snoo FA et al (2008) Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 14(21):7151\u20137157. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0403","journal-title":"Clin Cancer Res"},{"issue":"8","key":"508_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","volume":"51","author":"H Helgadottir","year":"2014","unstructured":"Helgadottir H et al (2014) High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet 51(8):545\u2013552. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102320","journal-title":"J Med Genet"},{"issue":"1","key":"508_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/hmg\/10.1.55","volume":"10","author":"JA Randerson-Moor","year":"2001","unstructured":"Randerson-Moor JA et al (2001) A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet 10(1):55\u201362. https:\/\/doi.org\/10.1093\/hmg\/10.1.55","journal-title":"Hum Mol Genet"},{"issue":"12","key":"508_CR36","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/ced.15354","volume":"47","author":"SL Wong","year":"2022","unstructured":"Wong SL, Martiniuc D, Kiuru M (2022) CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome. Clin Exp Dermatol 47(12):2284\u20132285. https:\/\/doi.org\/10.1111\/ced.15354","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"508_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/jmedgenet-2015-103446","volume":"53","author":"MJ Baker","year":"2016","unstructured":"Baker MJ et al (2016) An interstitial deletion within 9p21.3 and extending beyond. J Med Genet 53(11):721\u2013727. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103446","journal-title":"J Med Genet"},{"issue":"1","key":"508_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-59","volume":"15","author":"S Frigerio","year":"2014","unstructured":"Frigerio S et al (2014) A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma. BMC Med Genet 15(1):59. https:\/\/doi.org\/10.1186\/1471-2350-15-59","journal-title":"BMC Med Genet"},{"issue":"10","key":"508_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/jmedgenet-2017-104690","volume":"54","author":"J Vengoechea","year":"2017","unstructured":"Vengoechea J, Tallo C (2017) A germline deletion of 9p21.3 presenting as familial melanoma, astrocytoma and breast cancer: clinical and genetic counselling challenges. J Med Genet 54(10):682\u2013684. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104690","journal-title":"J Med Genet"},{"issue":"4","key":"508_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/bjd.14485","volume":"175","author":"MR Sargen","year":"2016","unstructured":"Sargen MR, Merrill SL, Chu EY, Nathanson KL (2016) CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature. Br J Dermatol 175(4):785\u2013789. https:\/\/doi.org\/10.1111\/bjd.14485","journal-title":"Br J Dermatol"},{"issue":"39","key":"508_CR41","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","volume":"20","author":"H Rizos","year":"2001","unstructured":"Rizos H et al (2001) A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 20(39):5543\u20135547. https:\/\/doi.org\/10.1038\/sj.onc.1204728","journal-title":"Oncogene"},{"issue":"11","key":"508_CR42","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/hmg\/11.11.1273","volume":"11","author":"C Hewitt","year":"2002","unstructured":"Hewitt C (2002) Germline mutation of ARF in a melanoma kindred. Hum Mol Genet 11(11):1273\u20131279. https:\/\/doi.org\/10.1093\/hmg\/11.11.1273","journal-title":"Hum Mol Genet"},{"issue":"1","key":"508_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/jmg.2005.033498","volume":"43","author":"K Laud","year":"2006","unstructured":"Laud K et al (2006) Comprehensive analysis of CDKN2A (p16INK4A\/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet 43(1):39\u201347. https:\/\/doi.org\/10.1136\/jmg.2005.033498","journal-title":"J Med Genet"},{"issue":"2","key":"508_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1073\/pnas.94.2.669","volume":"94","author":"DE Quelle","year":"1997","unstructured":"Quelle DE, Cheng M, Ashmun RA, Sherr CJ (1997) Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci U S A 94(2):669\u2013673. https:\/\/doi.org\/10.1073\/pnas.94.2.669","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"508_CR45","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1212\/wnl.43.9.1728","volume":"43","author":"DK Kaufman","year":"1993","unstructured":"Kaufman DK, Kimmel DW, Parisi JE, Michels VV (1993) A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma. Neurology 43(9):1728\u20131731. https:\/\/doi.org\/10.1212\/wnl.43.9.1728","journal-title":"Neurology"},{"issue":"9","key":"508_CR46","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/1097-0142(19951101)76:9<1571::aid-cncr2820760912>3.0.co;2-6","volume":"76","author":"E Azizi","year":"1995","unstructured":"Azizi E et al (1995) Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome. Cancer 76(9):1571\u20131578. https:\/\/doi.org\/10.1002\/1097-0142(19951101)76:9%3c1571::aid-cncr2820760912%3e3.0.co;2-6","journal-title":"Cancer"},{"issue":"1","key":"508_CR47","first-page":"96","volume":"53","author":"EM Petty","year":"1993","unstructured":"Petty EM et al (1993) Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). Am J Hum Genet 53(1):96\u2013104","journal-title":"Am J Hum Genet"},{"issue":"11","key":"508_CR48","first-page":"2298","volume":"58","author":"M Bahuau","year":"1998","unstructured":"Bahuau M et al (1998) Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58(11):2298\u20132303","journal-title":"Cancer Res"},{"issue":"21","key":"508_CR49","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-19-1429","volume":"80","author":"KE Chaney","year":"2020","unstructured":"Chaney KE et al (2020) Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. Cancer Res 80(21):4720\u20134730. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1429","journal-title":"Cancer Res"},{"issue":"10","key":"508_CR50","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/humu.24424","volume":"43","author":"C Perez-Becerril","year":"2022","unstructured":"Perez-Becerril C et al (2022) Screening of potential novel candidate genes in schwannomatosis patients. Hum Mutat 43(10):1368\u20131376. https:\/\/doi.org\/10.1002\/humu.24424","journal-title":"Hum Mutat"},{"issue":"7","key":"508_CR51","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","volume":"17","author":"P Mittal","year":"2020","unstructured":"Mittal P, Roberts CWM (2020) The SWI\/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol 17(7):435\u2013448. https:\/\/doi.org\/10.1038\/s41571-020-0357-3","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"508_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0092-8674(00)00030-1","volume":"102","author":"DA Bochar","year":"2000","unstructured":"Bochar DA et al (2000) BRCA1 is associated with a human SWI\/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102(2):257\u2013265. https:\/\/doi.org\/10.1016\/s0092-8674(00)00030-1","journal-title":"Cell"},{"issue":"12","key":"508_CR53","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1074\/jbc.M009747200","volume":"276","author":"MW Strobeck","year":"2001","unstructured":"Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES (2001) The BRG-1 subunit of the SWI\/SNF complex regulates CD44 expression. J Biol Chem 276(12):9273\u20139278. https:\/\/doi.org\/10.1074\/jbc.M009747200","journal-title":"J Biol Chem"},{"issue":"3","key":"508_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00401-014-1323-x","volume":"128","author":"M Hasselblatt","year":"2014","unstructured":"Hasselblatt M et al (2014) SMARCA4-mutated atypical teratoid\/rhabdoid tumors are associated with inherited germline alterations and poor prognosis. Acta Neuropathol 128(3):453\u2013456. https:\/\/doi.org\/10.1007\/s00401-014-1323-x","journal-title":"Acta Neuropathol"},{"issue":"12","key":"508_CR55","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","volume":"20","author":"K Mardinian","year":"2021","unstructured":"Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R (2021) Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy. Mol Cancer Ther 20(12):2341\u20132351. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0433","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"508_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","volume":"9","author":"L Witkowski","year":"2016","unstructured":"Witkowski L, Goudie C, Foulkes WD, McCluggage WG (2016) Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent developments on pathogenesis. Surg Pathol Clin 9(2):215\u2013226. https:\/\/doi.org\/10.1016\/j.path.2016.01.005","journal-title":"Surg Pathol Clin"},{"issue":"4","key":"508_CR57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/path.4427","volume":"234","author":"MJ Smith","year":"2014","unstructured":"Smith MJ et al (2014) Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol 234(4):436\u2013440. https:\/\/doi.org\/10.1002\/path.4427","journal-title":"J Pathol"},{"issue":"23","key":"508_CR58","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1056\/NEJMc1803354","volume":"378","author":"L de Kock","year":"2018","unstructured":"de Kock L et al (2018) Infantile pulmonary teratoid tumor. N Engl J Med 378(23):2238\u20132240. https:\/\/doi.org\/10.1056\/NEJMc1803354","journal-title":"N Engl J Med"},{"issue":"2","key":"508_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","volume":"44","author":"DL Kolin","year":"2020","unstructured":"Kolin DL et al (2020) SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities. Am J Surg Pathol 44(2):263\u2013270. https:\/\/doi.org\/10.1097\/PAS.0000000000001375","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"508_CR60","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/jmg-2022-108854","volume":"60","author":"L Witkowski","year":"2023","unstructured":"Witkowski L et al (2023) Germline pathogenic. J Med Genet 60(10):987\u2013992. https:\/\/doi.org\/10.1136\/jmg-2022-108854","journal-title":"J Med Genet"},{"issue":"1\u20132","key":"508_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","volume":"1660","author":"M Turunen","year":"2004","unstructured":"Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660(1\u20132):171\u2013199. https:\/\/doi.org\/10.1016\/j.bbamem.2003.11.012","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"508_CR62","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1172\/JCI45693","volume":"121","author":"SF Heeringa","year":"2011","unstructured":"Heeringa SF et al (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121(5):2013\u20132024. https:\/\/doi.org\/10.1172\/JCI45693","journal-title":"J Clin Invest"},{"issue":"10","key":"508_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/gim.2014.39","volume":"16","author":"K Zhang","year":"2014","unstructured":"Zhang K et al (2014) A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis. Genet Med 16(10):787\u2013792. https:\/\/doi.org\/10.1038\/gim.2014.39","journal-title":"Genet Med"},{"issue":"8","key":"508_CR64","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-2004","volume":"67","author":"E Pasmant","year":"2007","unstructured":"Pasmant E, Laurendeau I, H\u00e9ron D, Vidaud M, Vidaud D, Bi\u00e8che I (2007) Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67(8):3963\u20133969. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2004","journal-title":"Cancer Res"},{"issue":"4","key":"508_CR65","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/gcc.1159","volume":"31","author":"F Petronzelli","year":"2001","unstructured":"Petronzelli F, Sollima D, Coppola G, Martini-Neri ME, Neri G, Genuardi M (2001) CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma\/neurofibroma kindred. Genes Chromosomes Cancer 31(4):398\u2013401. https:\/\/doi.org\/10.1002\/gcc.1159","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"508_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.8.e102","volume":"40","author":"AH Prowse","year":"2003","unstructured":"Prowse AH et al (2003) Identification of a splice acceptor site mutation in p16INK4A\/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred. J Med Genet 40(8):e102. https:\/\/doi.org\/10.1136\/jmg.40.8.e102","journal-title":"J Med Genet"},{"issue":"6","key":"508_CR67","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/ajmg.a.35884","volume":"161A","author":"R Vanneste","year":"2013","unstructured":"Vanneste R, Smith E, Graham G (2013) Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome. Am J Med Genet A 161A(6):1425\u20131431. https:\/\/doi.org\/10.1002\/ajmg.a.35884","journal-title":"Am J Med Genet A"},{"key":"508_CR68","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/npjgenmed.2016.15","volume":"1","author":"SH Chan","year":"2016","unstructured":"Chan SH et al (2016) Germline hemizygous deletion of. NPJ Genom Med 1:16015. https:\/\/doi.org\/10.1038\/npjgenmed.2016.15","journal-title":"NPJ Genom Med"},{"issue":"5","key":"508_CR69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5414\/NP301022","volume":"36","author":"AK Chan","year":"2017","unstructured":"Chan AK et al (2017) Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A\/B deletion and a significant family history. Clin Neuropathol 36(5):213\u2013221. https:\/\/doi.org\/10.5414\/NP301022","journal-title":"Clin Neuropathol"},{"issue":"11","key":"508_CR70","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1097\/CORR.0000000000001239","volume":"478","author":"BJ Min","year":"2020","unstructured":"Min BJ, Kang YK, Chung YG, Seo ME, Chang KB, Joo MW (2020) Germline mutations for novel candidate predisposition genes in sporadic schwannomatosis. Clin Orthop Relat Res 478(11):2442\u20132450. https:\/\/doi.org\/10.1097\/CORR.0000000000001239","journal-title":"Clin Orthop Relat Res"},{"key":"508_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006164","author":"MR Jensen","year":"2022","unstructured":"Jensen MR et al (2022) 9p21.3 microdeletion involving. Cold Spring Harb Mol Case Stud. https:\/\/doi.org\/10.1101\/mcs.a006164","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"508_CR72","doi-asserted-by":"publisher","first-page":"1437093","DOI":"10.3389\/fonc.2025.1437093","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li X, Gao H, Qiu C, Liu X (2025) Case report: The smallest 9p21.3 microdeletion involving. Front Oncol 15:1437093. https:\/\/doi.org\/10.3389\/fonc.2025.1437093","journal-title":"Front Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00508-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00508-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00508-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:17:34Z","timestamp":1765009054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00508-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00508-1","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Given that this is a review study, no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"87"}}